Cedilla Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

For 60 years, sequence and structure has been the primary lens to understand protein function. It’s now time to look beyond and leverage the orchestration of protein function within cells. 

Cedilla Therapeutics is bringing a new dimension to precision oncology. We have discovered new ways to selectively inhibit oncogenic drivers with small molecules that conditionally modulate proteins in their functional state. Our conditional inhibitors are unlocking critical and elusive cancer targets including TEAD and CDK2. 

We are a driven and patient-focused team. 

Sign up for free to view info Email Format Employee directory